HemoSense And ZyCare Partner With Pima Heart To Utilize Web-Based Warfarin Patient Management System
San Jose, CA & Chapel Hill, NC - HemoSense, Inc. and ZyCare, Inc. recently announced that Pima Heart, a cardiology practice that provides medical and surgical services in southern Arizona, will use ZyCare's CoagCare software management system to remotely manage Pima Heart patients who wish to use HemoSense's portable INRatio PT/INR monitoring system for self-testing. CoagCare will also be used as the point-of-care anticoagulation management software in all seven Pima Heart locations.
After performing a PT/INR test with the INRatio system, patients use a standard Internet browser to input INR test results and information about symptoms and illness into the CoagCare system. CoagCare then provides automated, patient specific warfarin dosage adjustments based on physician-prescribed algorithms. Test results are immediately available to healthcare providers, and patients who report out of range INR values, hemorrhagic, or thromboembolic symptoms, are prioritized for physician review. CoagCare is the only U.S. Food and Drug Administration (FDA) cleared, HIPAA compatible remote INR test reporting and dosage management system for patients on oral anticoagulant therapy.
"Pima Heart currently utilizes our INRatio system in its anticoagulation clinics and the expansion of this relationship is a testament to the technical capabilities and versatility of our INRatio product, as well as the strength of ZyCare's Web-based management tools," said Timothy Still, executive VP and chief commercial officer of HemoSense.
"Of the millions of people taking warfarin there is a tremendous opportunity to improve their care and lives through more frequent testing, better monitoring and education," said Ted Ranney, Pima Heart chief executive officer. "We believe that the promotion of home-testing and offering additional management tools assist in affording patients this opportunity. We are excited to offer this new service to our patients."
Pima Heart currently manages more than 1,000 patients taking warfarin. By using the INRatio and instituting the CoagCare system, Pima Heart expects to be able to reduce the number of patient visits to its clinics, while effectively managing patient self-testers, so that it can focus on the critical patients who need the most attention.
"We are delighted with the expansion of our relationship with HemoSense, and our new relationship with a patient-focused organization such as Pima Heart, in order to bring the benefits of CoagCare and 'supervised self-management' to the patients of southern Arizona," said Sandra Cummings, president of ZyCare.
SOURCE: HemoSense, Inc.